MENU
CRIS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Curis (CRIS) Ownership - Who owns Curis?
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.71M
P/E Ratio
N/A
Total Cash
20.85M
Projected Growth
N/A
Total Debt
3.26M
Revenue
10.26M
Risk (Beta)
3.67
Dividend Yield
N/A
Total Cash/Share
1.99
Total Debt/Equity
74.54
Revenue/Share
1.73 USD as % of share price
Fundamentals
CRIS
Capitalization
13.7M
P/E Ratio
N/A
Risk (Beta)
3.67
Dividend Yield
N/A
Total Cash
20.9M
Total Cash/Share
1.99
Total Debt
3.26M
Total Debt/Equity
74.54
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.73%
Revenue
10.3M
ROE
N/A
Book Value
-8.74M
P/B Ratio
3.41
Cash Flow
N/A
Earnings
-7.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
60K
Current Ratio
1.22
Current Revenue Per Employee
59816.33
Dividends Per Share - Security
N/A
EBITDA
-44.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.25
Revenue To Assets
-68.68
Shares Held By Institutions
11.3M
Shares Outstanding - Current
10.5M
Total Liabilities
51.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-57.190
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a drug company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com